IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 192 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $677 | -37.7% | 63,606 | -38.4% | 0.07% | -36.4% |
| Q1 2023 | $1,086 | +43.8% | 103,258 | +69.4% | 0.11% | +13.8% |
| Q4 2022 | $755 | -99.8% | 60,949 | +27.1% | 0.09% | +42.4% |
| Q3 2022 | $497,000 | +310.7% | 47,942 | +356.5% | 0.07% | +266.7% |
| Q2 2022 | $121,000 | -88.3% | 10,501 | -87.2% | 0.02% | -87.0% |
| Q1 2022 | $1,031,000 | +20.4% | 81,981 | -13.9% | 0.14% | -3.5% |
| Q3 2020 | $856,000 | -25.0% | 95,165 | +11.0% | 0.14% | +7.5% |
| Q4 2019 | $1,141,000 | +58.0% | 85,714 | +1.9% | 0.13% | +35.7% |
| Q3 2019 | $722,000 | +317.3% | 84,087 | +465.7% | 0.10% | +600.0% |
| Q4 2013 | $173,000 | +11.6% | 14,864 | -4.7% | 0.01% | -22.2% |
| Q2 2013 | $155,000 | – | 15,599 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
| 13D Management LLC | 600,431 | $6,923,000 | 3.06% |
| BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
| Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
| Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
| Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
| ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
| Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
| CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |